Georges Assaf

Georges Assaf currently serves as a Principal Scientist at UCB, where responsibilities include leading drug substance projects through process development, knowledge and risk management, and transfer to production, from pre-clinical stages to launch. Key achievements include validation activities of a complex process involving standard chemical steps and purification by MCC across two manufacturing sites between 2018 and 2020. Previously, Georges worked as a Senior Scientist at UCB, focusing on diverse API structures and knowledge transfer related to outsourcing activities, specifically in China. Earlier experience includes roles at Lonza, Pfizer, AirLiquide, and Eli Lilly and Company, with a strong emphasis on process engineering, development, and support within the pharmaceutical industry. Educational qualifications encompass degrees from École Polytechnique and ENSTA Paris in chemistry and chemical engineering.